Lorazepam Tablet
Product Images NDC 70518-1679

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 70518-1679). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Lorazepam 2 mg oral tablets packaging label by RemedyRepack Inc. The label indicates the product is a Schedule IV controlled substance with a quantity of 30 tablets. It includes NDC 70518-1679-00, manufacturer information, storage instructions, and warnings about federal transfer restrictions and keeping medication out of children's reach.*

FDA Label Image

Lorazepam Structure (Lorazepam Structure)

Chemical structure of Lorazepam showing the molecular formula C15H10Cl2N2O2 and molecular weight 321.16. The diagram depicts the arrangement of atoms and bonds characteristic of the Lorazepam molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.